ChemicalBook > CAS DataBase List > NO-1886

NO-1886

Product Name
NO-1886
CAS No.
133208-93-2
Chemical Name
NO-1886
Synonyms
NO-1886;OPF 009;ibrolipim;Ibrolipim NO-1886;NO-1886 Ibrolipim;Ibrolipim, 10 mM in DMSO;Lipoprotein Lipase Activator;4-diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide;Diethyl 4-[(4-bromo-2-cyanophenyl)carbamoyl]benzylphosphonate;N-(4-bromo-2-cyanophenyl)-4-(diethoxyphosphorylmethyl)benzamide
CBNumber
CB5497355
Molecular Formula
C19H20BrN2O4P
Formula Weight
451.25
MOL File
133208-93-2.mol
More
Less

NO-1886 Property

Melting point:
160.5-162.1 °C
Boiling point:
512.5±50.0 °C(Predicted)
Density 
1.44±0.1 g/cm3(Predicted)
storage temp. 
Sealed in dry,2-8°C
solubility 
DMSO: ≥20mg/mL
form 
powder
pka
11.51±0.70(Predicted)
color 
off-white to pale yellow
More
Less

Safety

Hazard Codes 
Xi,T
Risk Statements 
36/37/38-25
Safety Statements 
26-36-45
RIDADR 
UN 2811 6.1 / PGIII
WGK Germany 
3
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Danger
Hazard statements

H301Toxic if swalloed

Precautionary statements

P301+P310IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
N1540
Product name
NO-1886
Purity
≥98% (HPLC)
Packaging
5mg
Price
$153
Updated
2025/07/31
Sigma-Aldrich
Product number
N1540
Product name
NO-1886
Purity
≥98% (HPLC)
Packaging
25mg
Price
$301.5
Updated
2025/07/31
Cayman Chemical
Product number
17425
Product name
NO-1886
Purity
≥98%
Packaging
5mg
Price
$86
Updated
2024/03/01
Cayman Chemical
Product number
17425
Product name
NO-1886
Purity
≥98%
Packaging
10mg
Price
$153
Updated
2024/03/01
Cayman Chemical
Product number
17425
Product name
NO-1886
Purity
≥98%
Packaging
25mg
Price
$343
Updated
2024/03/01
More
Less

NO-1886 Chemical Properties,Usage,Production

Uses

Antiatherogenic; antiobesity; antidyslipidemia; anticachexia; and antidiabetes/syndrome.

Uses

Lipoprotein Lipase Activator is an inducer of lipoprotein lipase mRNA.

Biological Activity

Lipoprotein lipase activator. Overexpression of lipoprotein lipase in transgenic rabbits leads to increased small dense LDL in plasma and promotes atherosclerosis. Long-term administration of NO-1886 protects against the development of experimental atherosclerosis in animals.

in vivo

Ibrolipim (NO-1886; 100 mg/kg; oral administration; daily; for 8 weeks; female Sprague-Dawley rats) treatment decreases accumulation of visceral fat and suppresses the increase in body weight resulting from the ovariectomy. Ibrolipim decreases the respiratory quotient and increases expression of the fatty acid translocase messenger RNA (mRNA) in the liver, soleus muscle, and mesenteric fat. Ibrolipim also increases the expression of fatty acid-binding protein mRNA in the liver and soleus muscle and the expression of the uncoupling protein 3 (UCP3) mRNA in the heart, soleus muscle, and mesenteric fat, but not in the brown adipose tissue[2].

Animal Model:Female Sprague-Dawley rats (10-week-old; 200-260 g) with experimental ovariectomy treatment[2]
Dosage:100 mg/kg
Administration:Oral administration; daily; for 8 weeks
Result:Decreased accumulation of visceral fat and suppressed the increase in body weight resulting from the ovariectomy.

NO-1886 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

NO-1886 Suppliers

Nanjing Dulai Biotechnology Co., Ltd.
Tel
025-846993838003-8003 18013301590
Fax
025-84699383-8003
Email
njduly@126.com
Country
China
ProdList
3249
Advantage
55
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Fax
021-65675885
Email
info@efebio.com
Country
China
ProdList
9803
Advantage
58
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Fax
QQ:3008007432
Email
3008007409@qq.com
Country
China
ProdList
71826
Advantage
60
Tianjin Kailiqi Biotechnology Co., Ltd.
Tel
15076683720
Fax
022-23754520
Email
klq@cw-bio.com
Country
China
ProdList
8011
Advantage
55
ShangHai Biochempartner Co.,Ltd
Tel
177-54423994 17754423994
Fax
QQ:2853530913
Email
2853530910@QQ.com
Country
China
ProdList
8000
Advantage
62
Beijing Solarbio Science & Tecnology Co., Ltd.
Tel
010-50973130 18101056239
Email
3193328036@qq.com
Country
China
ProdList
29760
Advantage
68
Shanghai Hongye Biotechnology Co. Ltd
Tel
400-9205774
Email
sales@glpbio.cn
Country
China
ProdList
6777
Advantage
58
HANGZHOU CLAP TECHNOLOGY CO.,LTD
Tel
86-571-88216897,88216896 13588875226
Fax
86-571-88216895
Email
sales@hzclap.com
Country
CHINA
ProdList
6312
Advantage
58
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
Tel
18818260767
Fax
QQ 3610331285
Email
sales@chemegen.com
Country
China
ProdList
11218
Advantage
58
Absin Bioscience Inc.
Tel
021-38015121 18438616290
Email
lanwu@univ-bio.com
Country
China
ProdList
24731
Advantage
58

133208-93-2, NO-1886Related Search:


  • Ibrolipim NO-1886
  • OPF 009
  • Lipoprotein Lipase Activator
  • N-(4-bromo-2-cyanophenyl)-4-(diethoxyphosphorylmethyl)benzamide
  • NO-1886
  • Diethyl 4-[(4-bromo-2-cyanophenyl)carbamoyl]benzylphosphonate
  • 4-diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide
  • ibrolipim
  • Diethyl 4-[(4-bromo-2-cyanophenyl)carbamoyl]benzylphosphonate, Ibrolipim, OPF 009
  • Phosphonic acid, [[4-[[(4-bromo-2-cyanophenyl)amino]carbonyl]phenyl]methyl]-, diethyl ester
  • obesity,fatty,inhibit,NO 1886,Ibrolipim,acid,NO1886,Inhibitor,lipoprotein,lipase,Antihyperlipidemic,UCP3,LDL-C,LXRα,HDL-C
  • NO-1886 Ibrolipim
  • Diethyl [[4-[[(4-bromo-2-cyanophenyl)amino]carbonyl]phenyl]methyl]phosphonate
  • Ibrolipim, 10 mM in DMSO
  • 133208-93-2
  • C19H20BrN2O4P
  • Br1C19H20N2O4P1